Osteoporosis & COVID-19
The global Covid-19 pandemic has greatly affected the prevention and care of chronic diseases such as osteoporosis. IOF has developed various educational resources and information to assist healthcare professionals, patient societies, and patients in adapting to the challenges related to assessment, treatment and lifestyle prevention for osteoporosis. See resources below.
RESOURCES FOR PATIENTS & PUBLIC
SCIENTIFIC PUBLICATIONS
HOW HAS COVID-19 AFFECTED THE TREATMENT OF OSTEOPOROSIS? An IOF-NOF-ESCEO global survey
Fuggle, N.R., Singer, A., Gill, C. et al. Osteoporos Int (2021)
GLOBAL IMPACT OF COVID-19 ON NON-COMMUNICABLE DISEASE MANAGEMENT: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
McCloskey, E.V., Harvey, N.C., Johansson, H. et al. Osteoporos Int (2020)
Webinars
HOW HAS COVID-19 AFFECTED OSTEOPOROSIS MANAGEMENT? THE PHYSICIANS’ & THE PATIENTS’ PERSPECTIVES
Key learning objectives:
- To recognize global impacts and issues raised by the COVID-19 pandemic within osteoporosis clinical management worldwide.
- To learn how patients have been affected.
- To understand continuous challenges and potential benefits that we can achieve in osteoporosis care management in both the short-term and post-pandemic.
OSTEOPOROSIS PRIMARY PREVENTION & TREATMENT CARE GAPS & IMPACT OF COVID19 ON ASSESSMENT & TREATMENT
Key learning objectives:
-
To review the current data of Osteoporosis epidemiology and burden across Europe
-
To further understand the treatment gap in Osteoporotic women across Europe
-
To learn impact of COVID-19 pandemic in the instance diagnosis and treatment of Osteoporotic patients in Europe
-
To illustrate the potential influence of anti-Osteoporosis treatment in the case of COVID-19 patients
¿Qué desafíos plantea COVID-19 para el paciente con fragilidad ósea? Guía clínica para el seguimiento de pacientes bajo tratamiento de osteoporosis durante la pandemia de COVID-19. Durante la primera Edición Especial del Meet The Expert Online 2020, el Dr. José Luis Neyro Bilbao compartió con nosotros su experiencia clínica desde España, dónde la pandemia está exigiendo al límite al sistema de salud.
CHALLENGES OF MANAGING PATIENTS WITH OSTEOPOROSIS DURING AND AFTER THE COVID19 PANDEMIC IN EUROPE
Key learning objectives :
- Clinical assessment and remote consultations
- Bone densitometry o Treatments
- Impact of changes in practice on HCPs
- Social distancing, self-isolation and bone health
HOW HAS COVID-19 AFFECTED OSTEOPOROSIS MANAGEMENT? THE PHYSICIANS’ & THE PATIENTS’ PERSPECTIVES
Key learning objectives:
- To recognize global impacts and issues raised by the COVID-19 pandemic within osteoporosis clinical management worldwide.
- To learn how patients have been affected.
- To understand continuous challenges and potential benefits that we can achieve in osteoporosis care management in both the short-term and post-pandemic.
MANAGING OSTEOPOROSIS PATIENTS DURING THE COVID-19 PANDEMIC
Held on June 12, 2020, this webinar covers topics of interest to all clinicians engaged in osteoporosis patient management. Speakers S. Papapoulos and A. Díez-Pérez discuss the impact of COVID-19 on the patient care pathway, how to identify patients at fracture risk, and how to ensure continuity of treatment.